Higher peak expiratory flow is associated with less frailty and lower risks of dementia, cognitive impairment, and sarcopenia in human cohorts. Associations with cognitive decline differ across studies, including a cohort showing no clear link with its rate; a hip-fracture association weakens after broader adjustment.
71 findings in 47 papers from 2016 to 2026, 8 of them since April 2026
“higher purpose in life was associated with better peak expiratory flow (meta-analytic effect = 0.07, p <.001)”
Fine particulate matter is linked with lower peak expiratory flow in humans (-8.480 (95% CI: 3.116, 13.845) decrease in PEF change).
“An interquartile range (IQR) increase in PM2.5 change was significantly related to an 8.480 (95% confidence interval [CI]: 3.116, 13.845) decrease in PEF change”
Clean cooking fuels are linked with better peak expiratory flow in humans.
“The use of clean cooking fuels throughout the survey and switch of solid fuels to clean fuels in 2013 were also significantly associated with higher PEF level.”
Peak expiratory flow is linked with worse cognitive function in individuals with lung diseases (0.14 vs. 0.065 words/year (immediate), 0.17 vs. 0.032 words/year (delayed)).
“Females with the lowest PEF values experienced the greatest rates of decline in immediate and delayed recall over 10 years of follow-up”
Humansin individuals with lung diseases10 yearsfemales
Peak expiratory flow was not clearly linked with clock drawing in individuals with lung diseases (females: t = 0.25, p = 0.81; males: t = -0.61, p = 0.55).
“There were no time-by-PEF interactions nor declines over time in clock drawing scores in both sexes”
Sarcopenia is linked with lower peak expiratory flow in an asthmatic population (P < 0.001).
“Linear mixed modeling results showed that asthmatics with sarcopenia had lower lung function (P < 0.001), and that this effect did not change over time.”
Sarcopenia is linked with lower peak expiratory flow in asthmatics (adjusted RR = 0.86, 95%CI: 0.82-0.91).
“an obvious reduction of PEF in the CHARLS and SAGE(sarcopenia yes vs. no, adjusted RR = 0.86, 95%CI: 0.82-0.91) compared to asthmatics without sarcopenia”
Blood pressure variability is linked with lower peak expiratory flow in humans (β = -0.224, 95% CI: -0.323 to -0.126).
“increased BPV was significantly associated with faster lung function decline [β for systolic BP: -0.224, 95% confidence interval (CI): -0.323 to -0.126”
Cognitive function is linked with peak expiratory flow in humans (via cognition→depression) (total indirect effect: 0.008, P = 0.001; 17% of total effect).
“Chain mediation showed metabolic phenotypes indirectly influenced PEF via cognition→depression (total indirect effect: 0.008, P = 0.001; 17% of total effect).”
Depressive symptoms are linked with lower peak expiratory flow in humans (b = -1.85, p < 0.001).
“Depressive symptoms were significantly associated with PEF among general middle-aged and older adults (b = -1.85, p < 0.001) after adjusting for multiple confounding factors.”
Peak expiratory flow is associated with frailty in humans (comparing lower 10-49th and < 10th SR percentile groups to 80-100th SR percentile group) (2-3 times higher prevalence).
“prevalence of frailty was 2-3 times higher in the lower 10-49th and < 10th SR percentile groups compared to the 80-100th SR percentile group.”
Humanscomparing lower 10-49th and < 10th SR percentile groups to 80-100th SR percentile groupn = 5,060
Peak expiratory flow predicts frailty in humans (adjusted for covariates, comparing PEF SR percentiles below the 10th to the 80th-100th) (HR 2.01 (95% CI, 1.15-3.51)).
“adjusted hazard ratio (HR) of 2.01 (95% CI, 1.15-3.51) for PEF SR percentiles below the 10th, in contrast to those between the 80th and 100th percentiles.”
Humansadjusted for covariates, comparing PEF SR percentiles below the 10th to the 80th-100thfour-yearn = 5,060
Peak expiratory flow is associated with frailty in humans (cross-sectional; lower PEF SR percentile categories vs 80th-100th) (three- and five-fold higher likelihood of being frail).
“the 10th-49th and <10th PEF SR percentile categories were associated with three- and five-fold higher likelihood of being frail than the 80th-100th category”
Humanscross-sectional; lower PEF SR percentile categories vs 80th-100th
Peak expiratory flow is linked with a lower risk of cognitive impairment in humans (OR = 0.93, 95% CI 0.90 to 0.97, p = 0.001).
“Higher PEF values (Q4 vs Q1: OR = 0.93, 95 % CI 0.90 to 0.97, p = 0.001) as well as elevated PEF% predicted (Q4 vs Q1: OR = 0.94, 95 % CI 0.90 to 0.97, p = 0.001) were associated with a reduced risk of developing CI onset.”
Peak expiratory flow is associated with motoric cognitive risk syndrome in humans (OR 3.04, 95% CI 1.85, 5.01).
“the <30 and 30-50 percentile groups had significantly higher odds of prevalent MCR (OR 3.04 [95% CI 1.85, 5.01]; OR 2.06 [95% CI 1.19, 3.54], respectively).”
Weight-adjusted-waist index is associated with peak expiratory flow in humans (β = −24.10 L/min, 95% CI: −29.01 to −19.19).
“each one-unit increase in WWI was associated with lower PEF (β = −24.10 L/min, 95% CI: −29.01 to − 19.19) and lower PEF%pred (β = −5.01%, 95% CI: −6.15% to − 3.87%) in males”
Peak expiratory flow is associated with incident hip fractures in humans (Primary confounder-adjusted model; association attenuated after broader adjustment) (HR 0.79 (95% CI 0.68–0.91) per 1-standard deviation higher PEF; broader-adjusted HR 0.87 (0.74–1.02)).
“Higher baseline PEF was associated with lower incident hip fracture risk in crude and partially adjusted analyses, but the association was attenuated after broader adjustment.”
HumansPrimary confounder-adjusted model; association attenuated after broader adjustmentPer 1-standard deviation higher baseline PEFUp to ~7 yearsn = 5,789
Peak expiratory flow is associated with first self-report of recognized lung disease in humans (ELSA; continuous PEF adjusted for separate FEV1 and FVC indices) (OR 1.04, 95% CI 0.90–1.20).
“After adjustment for separate FEV1 and FVC indices, the continuous-PEF OR was 1.04 (0.90-1.20).”
HumansELSA; continuous PEF adjusted for separate FEV1 and FVC indices
Six-minute walking distance was 64.20 meters greater with breathing-focused exercise than with no exercise, compared with 57.33 meters greater with standard exercise.Six-minute walking distance was 64.20 meters greater with breathing-focused exercise than with no exercise, compared with 57.33 meters greater with standard exercise.
Who was studied51 people with obesity, against controls receiving no exercise intervention
What changedSix-minute walking distance was 57.33 meters greater with standard exercise and 64.20 meters greater with breathing-focused exercise than controls
The catchExercise programs lasted only 10 weeks, leaving longer-term walking benefits unmeasured
A 12-week randomized trial of 69 adults aged 60–85 found differences between groups in breathing-muscle strength and selected biological markers, but not lung function.A 12-week randomized trial of 69 adults aged 60–85 found differences between groups in breathing-muscle strength and selected biological markers, but not lung function.
Compared with the low, steady index group, moderately rising and high, steady groups had lower lung-problem odds: odds ratios of 0.80 and 0.75, respectively.Compared with the low, steady index group, moderately rising and high, steady groups had lower lung-problem odds: odds ratios of 0.80 and 0.75, respectively.
Accepted, not yet published: cohort · 2,414 peoplePopulations
Who was studied2,414 middle-aged and older Chinese adults, against low-stable TyG-BMI group
What changedChronic respiratory disease odds were lower with high-stable versus low-stable index levels (OR=0.75), mainly reflecting breathing-test impairment
The catchThe combined disease outcome mixed breathing-test impairment with self-reported disease showing the opposite association